US Patent 11466079 C-terminal antibody variants

Patent 11466079 was granted and assigned to Amgen on October, 2022 by the United States Patent and Trademark Office.

Is a

Patent Applicant

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

October 11, 2022

Patent Application Number

16971590

Date Filed

March 29, 2019

Patent Citations Received

Patent Primary Examiner

The invention generally relates to anti-sclerostin antibodies having C-terminal modifications, and compositions comprising such antibodies.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 11466079 C-terminal antibody variants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

By using this site, you agree to our Terms of Service.